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Abstract
Early diagnosis and treatment are critical to preventing HIV-related complications and 
transmission for adolescents and young adults with HIV (AYAWH). The Metropolitan Atlanta 
Community Adolescent Rapid Testing Initiative (MACARTI) was a single center, prospective, 
nonrandomized, interventional control group study incorporating motivational interviewing (MI) 
psychotherapy strategies with community outreach, HIV testing, and intensive case management 
(CM). This sub-study of MACARTI examined how the MI and CM components influenced 
psychological distress, proactive coping, HIV/AIDS stress, and HIV stigma in association with 
HIV disease markers (HIV viral load [VL] and CD4+ T-cell [CD4+] counts). Ninety-eight 
AYAWH (Mage =21.5±1.8, range 18–24) were allocated to either the standard of care (n=49) or 
MACARTI (n=49) arms and results were compared between these two groups. Baseline and 
follow-up surveys measured psychological distress, proactive coping, HIV/AIDS stress, and HIV 
stigma. MACARTI arm assignment was associated with statistically significant reductions in 
psychological distress (p=0.016), HIV/AIDS stress (p=0.023), and the use of more reflective 
coping (p=0.016) and strategic planning strategies (p=0.001) during the first six months. These 
results did not remain significant at one-year follow-up but may still provide support for the 
integration of psychotherapy strategies into HIV identification, linkage, and retention efforts in the 
future.
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The United States (U.S.) HIV epidemic disproportionately affects adolescents and young 
adults ages 13 to 24 (Centers for Disease Control and Prevention [CDC], 2018a). 
Adolescents and young adults with HIV (AYAWH) made up 21% of new diagnoses in the 
U.S. in 2017 (CDC, 2018b) and are the least likely age group to connect to care and attain 
viral suppression. As such, novel strategies intended to identify, link, and retain AYAWH in 
medical care are critically needed. Psychological distress and HIV-related stress are linked 
with numerous barriers to receiving timely medical care and reduced quality of life for 
people living with HIV (Pakenham & Rinaldis, 2002). Furthermore, HIV stigma is 
associated with poor linkage, retention, and engagement in care, reduced adherence, 
decreased HIV testing and condom usage, and loneliness (Mahajan et al., 2008; Dowson, 
Kober, Perry, Fisher, & Richardson, 2012; Smit et al., 2012; Hubach et al., 2015; Eaton et 
al., 2015). These findings highlight the need for HIV care identification, linkage, and 
retention approaches to attend to behavioral health factors in order to optimize clinical 
outcomes, including strategies that increase proactive coping behaviors and reduce 
psychological distress, HIV/AIDS stress, and HIV stigma.
The Metropolitan Atlanta Community Adolescent Rapid Testing Initiative (MACARTI) was 
a pilot single center, prospective non-randomized interventional study of AYAWH that began 
with a formative phase comprised of conducting focus groups of youth with and without 
HIV and engagement in ethnographic studies in order to understand testing preferences and 
discover non-traditional testing venues. MACARTI was developed to identify AYAWH early, 
link and retain them in HIV care, and increase their adherence to medical treatment by 
simultaneously addressing developmental, social, psychological, and economic barriers to 
care. MACARTI exemplifies this multilevel approach by combining non-traditional venue 
HIV testing, brief psychotherapy informed by motivational interviewing (MI) strategies, and 
strengths-based case management services (CM).
MI, an evidence-based, person-centered psychotherapy approach that promotes behavior 
change by resolving ambivalence and strengthening intrinsic motivation, has been shown to 
enhance positive health-related behavioral change (Hill & Kavookjian, 2012; Konkle-Parker, 
Erlen, Dubbert, & May, 2012). Based on the transtheoretical model (Prochaska & 
DiClemente, 1992), MI encourages collaboration, evocation, and autonomy. MI principles 
include expressing empathy, developing discrepancy, rolling with resistance, and supporting 
self-efficacy (Miller & Rollnick, 2013). MI is a brief, yet flexible approach that can be 
delivered in about two to four sessions by providers within a multidisciplinary team and 
tailored to the needs of diverse populations (Hetema, Steele, & Miller, 2005; Parsons, Golub, 
Rosof, & Holder, 2007). Brief MI interventions targeting HIV risk behaviors in AYAWH 
have been shown to improve motivation, depression, and viral loads (Naar-King et al., 2009, 
2010). CM services also have been found to increase engagement and retention of ethnic 
minority AYAWH in care; particularly those that aided in clinic/provider access, housing 
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assistance, food insecurity, and navigating a complex health system (Johnson et al., 2003; 
Wohl et al., 2011).
Given the importance of attending to psychological and psychosocial factors in enhancing 
HIV-associated outcomes, this study aimed to explore how MACARTI influenced 
associations between psychological distress, proactive coping, HIV/AIDS stress, HIV 
stigma, and medical outcomes in AYAWH. It was hypothesized that the brief MI-informed 
therapy and CM components of MACARTI would reduce psychological distress, HIV/AIDS 
stress, HIV stigma, and support proactive coping. Additionally, it was hypothesized that 
psychological distress, HIV/AIDS stress, and HIV stigma would be positively associated 
with viral load and negatively associated with CD4+ count, each of which are key HIV 
medical outcomes.
Methods
Participants
The study included 98 participants. Eligibility requirements for all subjects included being: 
(1) 18 to 24 years of age; (2) newly diagnosed with HIV (never tested positive for HIV prior 
to the start of the study); (3) treatment naive (never received HIV medical care); and (4) a 
first-time enrollee in care at this HIV care clinic. New HIV diagnoses were later confirmed 
through the various county health departments. Screening and enrollment began in 
December 2012 and ended in January 2016. During Phase 1 of MACARTI, focus groups 
comprised of HIV positive and at-risk adolescents and young adults were used to identify 
the non-traditional HIV testing venues used to recruit MACARTI participants. Although this 
method more efficiently identified and linked AYAWH to HIV care (Camacho et al., 2017; 
Murray et al., 2018), a primary aim of the overall study, it prohibited the randomization of 
the two study arms as the SOC participants were referred differently (from community HIV 
volunteer organizations).
Study Procedures
Participants were enrolled in the Standard of Care (SOC) or MACARTI intervention arm (49 
in each arm; see Table 1 for demographics). SOC participants were enrolled via traditional 
referrals from community HIV volunteer organizations and received HIV care in accordance 
with established practice standards. Of the 62 SOC participants recruited via flyers and in-
person solicitation after presenting for enrollment at the clinic, 49 were new to HIV care and 
subsequently enrolled. Following linkage and engagement in HIV care, SOC participants 
were given access to standard CM (referrals to housing, food assistance, and transportation) 
and/or psychotherapy services in a co-located mental health clinic, though their participation 
was self-initiated or by referral following engagement in care.
MACARTI participants were enrolled via the non-traditional HIV testing venues identified 
in the first phase and were recruited by study staff following rapid initial HIV testing in 
these settings (e.g., clubs, bars, libraries). Prior to testing, participants received brief MI-
focused intervention to plan for test results. Participants testing negative were provided 
education on HIV prevention strategies while participants testing positive were offered 
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emotional support, CM, and accelerated enrollment assistance linking them to HIV care. 
Once linked, they received upfront MI-informed counseling sessions and intensive case 
management services. Of 435 total participants tested, 49 received a positive HIV test result 
and were assigned to the MACARTI arm.
MACARTI participants received a minimum of five, 30–45 minute, MI informed therapy 
sessions administered by either a clinical social worker or psychology postdoctoral fellow 
under the supervision of a licensed psychologist. These sessions were provided prior to and 
concurrent with medical treatment and coincided with their enrollment, 30-day, 90-day, 6-
months, and 12-month study visits. MACARTI sessions focused on helping participants 
adapt to the psychological sequela following a new HIV diagnosis, exploring ambivalence in 
making positive health behavior changes, developing a manageable and realistic plan that 
follow best practices for managing HIV medical care, and adopting a way of life to sustain 
positive, long-term health behaviors. The agenda for the sessions was set by participants 
based on current concerns and centered on skills practice in exploring ambivalence about 
treatment, improving communication, developing, assessing progress, and revising goals as 
needed, empowering participant’s strategies for goal attainment, and reinforcing self-
efficacy. MACARTI participants were encouraged to participate in additional sessions as 
needed as goals changed or were achieved. Approximately 10% of these participants elected 
for additional sessions. A detailed account of the MACARTI methodology is presented by 
Camacho-Gonzalez et al. (2017) and Murray et al. (2018).
The MACARTI outreach coordinator also served as a patient navigator, providing CM 
before, during, and between study visits. This coordinator maintained frequent contact 
through various outreach methods (phone calls, texts, in-person visits) and facilitated 
attendance to medical appointments, provided guidance on maneuvering through a complex 
health system, and connected them to services such as housing, transportation, health 
insurance programs, food assistance, etc.
At baseline, 1-, 3-, 6-, and 12-month time intervals, participants completed surveys via audio 
computer-assisted self-interviewing (ACASI) that included measures of psychological 
distress, proactive coping, HIV/AIDS stress, and HIV stigma. Researchers also collected 
viral load, CD4+ T-cell count, and appointment attendance data from the medical record. 
The Emory University Institutional Review Board approved this protocol.
Measures of Psychological and Psychosocial Variables
Psychological Distress.—The Kessler Psychological Distress Scale (K10) (Kessler et 
al., 2002) consists of 10 items, measuring frequency of symptoms of anxiety and depression 
on a five-point Likert scale ranging from 1 (none of the time) to 5 (all of the time), with 
higher scores reflecting greater perceived distress and severity of symptoms. A score of 20 
or above is suggestive of the presence of a mental disorder (State of Victoria, Department of 
Human Services, 2002). The K10 has good internal consistency with a Cronbach’s alpha of 
0.93 (Kessler et al., 2003). The current sample’s alpha was 0.93.
Proactive Coping.—The Proactive Coping Inventory (PCI) is a 55-item measure designed 
to assess diverse aspects of proactive coping and consists of seven subscales: proactive 
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coping, preventive coping, reflective coping, strategic planning, instrumental support 
seeking, emotional support seeking and avoidance coping. Coping behavior statements are 
rated on a four-point Likert scale ranging from 1 (not at all true) to 4 (completely true), with 
higher scores reflecting greater agreement with the coping behavior. The PCI and its 
subscales have high internal consistency (e.g., Cronbach alphas range from 0.71 to 0.85) 
(Greenglass, Schwarzer, Jakubiec, Fiksenbaum, & Taubert, 1999). The current sample’s 
alphas ranged from 0.85 to 0.94.
HIV/AIDS Stress.—HIV/AIDS Stress Scale consists of 29 items on a five-point Likert 
scale ranging from 0 (not at all) to 4 (extremely) within the past month (Pakenham & 
Renaldis, 2002). Higher scores reflect greater HIV-related stress. The HIV/AIDS Stress 
Scale has high internal consistency and reliability (r = 0.85) (Pakenham & Renaldis, 2002). 
The current sample’s alpha was 0.92.
Stigma.—The 13-item HIV Stigma Scale (Sowell et al., 1997) assesses perceived HIV 
stigma using a four-point Likert scale ranging from 0 (not at all) to 4 (often) to rate the 
frequency of feeling stigmatized because of one’s HIV status. Higher scores indicate higher 
perceptions of stigma and the scale contains three subscales: Distancing (form of social 
rejection), Blaming (conferring blame for contracting HIV), and Discrimination 
(mistreatment and prejudicial treatment by others) (Emlet, 2005). Cronbach’s alphas for the 
HIV Stigma Scale ranged from 0.83 to 0.88 (Emlet, 2005). The current sample’s alpha was 
0.96
Statistical Analyses
Statistical analyses were performed using SAS v.9.4 (Cary, NC) and CRAN R v.3.3 (Vienna, 
Austria), and significance was evaluated two-sided at the 0.05 level. Demographic, drug use, 
sexual history, and clinical characteristics were summarized overall and by SOC and 
MACARTI arms using means and standard deviations, medians and interquartile ranges 
(IQR), or frequencies and percentages as appropriate. Two-sample testing, including both 
parametric (t-tests and Chi-square tests) and non-parametric (Wilcoxon and Fisher’s) 
approaches were used to gauge dissimilarities between the study groups at baseline. Due to 
noted baseline covariate disparities between SOC and MACARTI arms (i.e. confounders), an 
inverse propensity-treatment weighted (IPTW) score was calculated, using binary logistic 
regression with a weighted standardized differences cutoff of 0.25, and added as an 
observation weight characteristic to the sample. These weighting methods are analogous to 
those utilized by Camacho-Gonzalez et al. (2017) and described in detail by Austin & Stuart 
(2015).
Linear mixed-effects growth models were employed to compare psychological measure 
differences and interactions within and between study arms from baseline (one month) to 
follow-up at 6 months and 12 months. To account for observed non-linear trends in 
psychological outcomes over time, separate regression models were run for data at baseline 
to 6 months and baseline to 12 months. For each growth model, the fixed effects were 
treatment arm (two levels) and study visit. Random effects were the participant-specific 
intercepts. Interactions were treatment arm by study visit and tested for differences in 
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outcome slopes (i.e., growth trends) between study arms. Model covariance was estimated 
separately for each arm to account for potential heterogeneity, and an unstructured variance-
covariance matrix was employed. Model-estimated mean differences and 95% confidence 
intervals were calculated from baseline to endpoint within each study arm and at endpoint 
between study arms for each outcome. Effect sizes were derived by dividing each mean 
difference by the corresponding pooled standard deviation at baseline. Effect sizes were 
given as a supplemental metric to evaluate outcome change (within arms) and differences 
(between arms), and interpreted as small (0.2), moderate (0.5), and large (0.7).
Linear mixed-effects regression models were used to consider statistical associations 
between psychological measures and clinical characteristics [CD4+ and viral load (VL)], 
across the SOC and MACARTI arms, adjusted for study visit follow-up. CD4+ counts were 
split at 500 cells (<500 versus ≥500), and VL was split at the limit of detection (≤40 versus 
>40). The fixed effects for each model were treatment arm (two levels) and clinical 
characteristic (CD4+ and VL, two levels). The random effects were participant-specific 
intercepts. Interactions were analogous to two-factor ANOVA and considered differences for 
all combinations of treatment arm and clinical characteristics. Pairwise comparisons were 
tested for all interaction levels, and p-values reported unadjusted. All observations in the 
regression analyses were evaluated weighted using the IPTW scores.
Results
Four hundred thirty-five participants were tested and 49 of those were identified as HIV+ 
and enrolled in the MACARTI arm. The SOC screened 62 participants and identified 49 
AYAWH meeting inclusion criteria. A total of 98 participants, 49 in each arm, were enrolled; 
91% self-identified as Black and/or African American, 85% male, mean age was 21 years 
(SD=1.8 years), 78% identified as lesbian, gay, bisexual, and queer (LGBQ), 62% had an 
education level of high school or less, 23% reported current drug use (alcohol and/or illicit 
substances), and 14% endorsed a history of physical and/or sexual abuse.
Kessler Psychological Distress
At six months, SOC patients saw a marginal decrease in K10 scores (Mean: −2.7, 95% CI: 
−5.6, 0.1, p=0.061), but scores remained above the cutoff score of 20 indicating a clinical 
level of psychological distress suggestive of the presence of a mental disorder (State of 
Victoria, Department of Human Services, 2002); conversely, MACARTI participants had a 
mean 3.6 (95% CI: −6.8, −0.5) point decline in K10 scores, reaching a 6-month value of 
17.9 (Table 2a). The decline in psychological distress by MACARTI patients from baseline 
to six months was statistically significant (p=0.024); however, the 6-month difference in K10 
scores between SOC and MACARTI patients was not significant (p=0.261) (Table 2b). At 
12-months, the mean SOC score remained above the clinical level of psychological distress 
(20.6, 95%: 17.1, 24.2), and the mean MACARTI score also returned to a clinical level of 
distress (23.3, 95% CI: 19.9, 26.8). There was no difference in mean K10 scores at 12 
months between SOC and MACARTI participants (2.7, 95% CI: −2.2, 7.6, p=0.276). There 
were no associations between K10 scores and clinical characteristics between study arms 
(Tables 3 and 4).
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Proactive Coping Inventory
At six months, significant declines in the reflective coping and strategic planning domains 
were observed in the SOC cohort, relative to baseline (Reflective Coping Mean Difference: 
−3.8, 95% CI: −5.7, −2, p<0.001; Strategic Planning Mean Difference: −2, 95% CI: −2.8, 
−1.2, p<0.001); whereas, no differences were observed in MACARTI participants (Table 
2a). At the 6-month study session, MACARTI participants had statistically significant higher 
reflective coping and strategic planning scores over SOC (Reflective Coping Difference: 3.3, 
95% CI: 0.2, 6.3, p=0.040; Strategic Planning Difference: 1.5, 95% CI: 0.3, 2.7, p=0.013) 
(Table 2b). At 12 months, reflective coping scores were not significantly different from 
baseline in either study arm. A significant difference in baseline to 12-month strategic 
planning scores was observed for SOC patients (Mean: −0.8, 95% CI: −1.4, −0.2, p=0.010), 
but no difference was observed in MACARTI participants (p=0.602) (Table 2a). Differences 
in 12-month scores between SOC and MACARTI patients for reflective coping and strategic 
planning were not significant (p=0.540 and p=0.397, respectively) (Table 2b).
For the clinical characteristics, reflective coping scores were significantly lower in SOC, 
relative to MACARTI, when CD4 ≥ 500 (p=0.046); moreover, strategic planning scores were 
marginally lower in SOC patients with CD4 ≥ 500, relative to all other groups (all p<0.1). 
For viral load, SOC patients with VL>40 had lower reflective coping scores than SOC and 
MACARTI patients with undetectable values (p=0.007 and p=0.097, respectively). No 
differences in strategic planning scores were observed between the study arm and VL groups 
(Tables 3 and 4).
HIV/AIDS Stress Scale
At both six and 12 months, SOC and MACARTI participants had decreases in mean HIV/
AIDS Stress Scale scores from baseline; however, none of these differences reached 
statistical significance within arm (Table 2a) or between arms (Table 2b). There were no 
associations between HIV/AIDS Stress Scale scores and clinical characteristics between 
study arms (Tables 3 and 4).
HIV Stigma Scale
At six months, SOC participants saw a marginally significant reduction in the discrimination 
domain of the HIV Stigma scale relative to baseline (Mean: −0.8, 95% CI: −1.7, 0.1, 
p=0.065); however, MACARTI patients had significant reductions in mean scores on the 
overall HIV Stigma Scale (−4.1, 95% CI: −6.8, −1.5, p=0.003), Distancing domain (−1.4, 
95% CI: −2.6, −0.2, p=0.018), and Blaming domain (−1.8, 95% CI: −2.8, −0.8, p=0.001), as 
well as a marginal reduction on the Discrimination domain (−0.8, 95% CI: −1.8, −0.2, 
p=0.098) (Table 2a). While differences existed within the study arms, there were no 6-month 
study visit differences between study groups (Table 2b). Even so, interaction p-values 
indicated significant differences in slopes for overall HIV Stigma (p=0.041), Distancing 
(p=0.008), and Blaming (p=0.044), pointing to steeper declines in score trends for 
MACARTI participants, relative to SOC. At 12 months, differences in mean distancing (1.6, 
95% CI: 0, 3.1, p=0.049) and discrimination (−1.2, 95% CI: −2.4, 0, p=0.057) scores were 
observed for SOC patients relative to baseline. Blaming was significantly lower in 
MACARTI participants (Mean: −1.6, 95% CI: −3, −0.2, p=0.026) (Table 2a). No differences 
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between SOC and MACARTI patients were observed at 12 months (Table 2b); however, 
trends in blaming scores showed statistically significant differences in trajectories, with 
MACARTI scores decreasing and SOC scores increasing (p=0.008). No associations were 
noted between CD4 counts and measure outcomes across the study cohorts. Significantly 
higher blaming scores were noted in MACARTI patients with viral loads >40 relative to 
those ≤40.
Clinical Outcomes, Retention, and Linkage to Care
Results relating to clinical outcomes (VL and CD4+ counts), linkage to care, and retention 
are reported elsewhere (Camacho-Gonzalez et al., 2017). MACARTI participants had fewer 
AIDS-defining conditions (20% vs 51%, p=0.002) and higher CD4+ counts at baseline than 
the SOC arm and continued a growth trajectory of CD4+ counts over follow-up that was 
higher relative to the SOC (p=0.004). While VL levels decreased significantly in both arms 
after one year, the proportion of participants who had undetectable VL after one year was 
higher in the MACARTI arm relative to the SOC arm (83 vs 41%, p<0.001). Fifty percent of 
the MACARTI participants attended 100% of their scheduled clinical visits comparted to 
26% of the SOC participants Camacho et al., 2017). These results support findings in the 
literature examining various intervention and observational studies that estimate 
approximately 51% of AYAWH achieve viral suppression, 62% are linked to care within 6–
12 months, and 43% are retained in care over 1–3 years and underscores the importance of 
needing targeted HIV testing (Zanoni & Mayer, 2014).
Discussion
Adolescents and young adults are disproportionately impacted by HIV. This multilevel, 
multicomponent intervention is one of the few studies aimed at identifying, linking, 
retaining, and increasing medical treatment adherence for AYAWH in HIV medical care. 
This sub-study of MACARTI examined the impact of MI and CM on a combination of self-
reported scores for psychological distress, proactive coping, HIV/AIDS stress, and HIV 
stigma in association with clinical outcomes. Results suggest that MACARTI was an 
effective method for maintaining proactive coping and reducing psychological distress and 
HIV stigma within six months of initiating the intervention. This suggests that using a 
multicomponent intervention can be helpful in not only linking, engaging, and retaining in 
care but also reducing distress in this high-risk population. However, these differences did 
not maintain statistical significance when compared between the study groups at 12 months 
and both populations endorsed elevated psychological distress at this time point. The 
MACARTI focus on medical care and health needs did not directly address other sources of 
psychological distress unless requested by the participant. Therefore, other sources of 
distress may have influenced scores on this measure. Future studies should better explore the 
nature of distress and potential factors contributing to the ebb and flow of other extraneous 
variables that could impact stress experienced by this population.
From the 6-month to the 12-month study visit, only two MI-focused therapy sessions were 
provided compared to the three sessions provided in the initial three months of the study. It 
is possible that reducing the frequency of services contributed to an increase in distress. 
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Prospective studies should focus on the number of sessions needed to adequately reduce 
distress and maintain these results. This intervention may have proved too brief and too 
specific in its focus on health behavior change to address other presenting concerns.
MACARTI participants showed statistically significant reductions in HIV stigma total 
scores, blaming, and distancing scores compared to the SOC participants. Although the 
study design precludes drawing causal conclusions regarding this finding, one possibility is 
that MACARTI helped to foster an accepting care environment (including clinical staff and 
peers) that had the effect of attenuating stigma. This idea is supported by previous research 
investigating the role of an “HIV competent community” that provides vital emotional 
support and practical advice, promotes access to services, and encourages medical care and 
treatment adherence (Campbell et al., 2013). Future research on the MACARTI intervention 
could explore this further, including the possible role of brief MI-informed therapy on 
facilitating the reduction of stigma in the context of the overall intervention.
On the HIV/AIDS Stress Scale there were no within group and between group statistically 
significant differences in the variable. Although the MACARTI arm placed more emphasis 
on the reduction HIV/AIDS stress, both study arms were provided psychoeducational 
presentations about topics, such as HIV disclosure and healthy relationships, that aimed to 
reduce stress and stigma and to improve interpersonal relationships as part of the standard of 
care at the clinic. It is possible the SOC arm benefitted sufficiently from these opportunities.
This study has some limitations of note. The small sample size and reliance on a 
convenience sample from a single site, geared towards underserved populations, without 
randomization limits the generalizability of the results. Consequently, future research is 
needed to test the MACARTI intervention using randomized designs in multiple clinical 
sites. Secondly, participant biases in testing site selection may have contributed to observed 
demographic differences in sexual orientation and gender identity between the study arms. 
This threat to external validity resulted in an oversampling of young, Black men who have 
sex with men (MSM) in the MACARTI arm. Another major study limitation is that the 
current design of the study does not permit for a deeper analysis of the specific effects 
associated with the different components of the MACARTI intervention. Future research 
could involve further evaluation to determine the specific effects associated with MI versus 
CM and other MACARTI components. One additional limitation is that MACARTI was 
designed to be a brief intervention to address linkage, engagement, and retention in care, 
future studies should examine the impact of more intensive therapy strategies intended to 
address psychological barriers to care and wellbeing.
Accounting for these study limitations, the current study provides evidence that a 
multicomponent intervention, such as MACARTI, that incorporates a psychotherapy 
intervention with case management can link, engage, and retain AYAWH in HIV-related care 
(Camacho, 2017). This intervention also provides support for incorporating psychotherapy 
intervention to favorably influence a reduction in psychological distress and improved 
proactive coping. Although these changes are only supported for the first six months of 
treatment, it shows some promise in addressing these variables. Furthering research to 
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include randomized controlled trials in multiple settings and across diverse demographic 
groups can further explicate the efficacy of the MACARTI model.
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Table 1:
Baseline characteristics for standard of care and intervention participants, the MACARTI Trial, Atlanta, 
Georgia, USA, 2012–2016
Characteristic, N (%) OverallN = 98
SOC
N = 49
MACARTI
N = 49
P-
Value
Unweighted
Std. Diff
Weighted
Std. Diff2
Gender
 Male 83 (84.7%) 36 (73.5%) 47 (95.9%) 0.004 0.656 0.097
 Female 15 (15.3%) 13 (26.5%) 2 (4.1%)
Race
 Black 89 (90.8%) 47 (95.9%) 42 (85.7%) 0.159 0.359 0.230
 Other (White, Hispanic, Other) 9 (9.2%) 2 (4.1%) 7 (14.3%)
Age (yr), Mean ± SD 21.5 ± 1.8 21.3 ± 1.8 21.7 ± 1.7 0.175 0.276 0.083
Work Status
 Employed/In School 74 (75.5%) 32 (65.3%) 42 (85.7%) 0.019 0.489 0.139
 Neither 24 (24.5%) 17 (34.7%) 7 (14.3%)
Education, N = 97
 High school or Less 60 (61.9%) 35 (72.9%) 25 (51%) 0.026 0.463 0.154
 College or More 37 (38.1%) 13 (27.1%) 24 (49%)
Ever Abused Alcohol 15 (15.3%) 3 (6.1%) 12 (24.5%) 0.022 0.528 0.083
Currently Using Drugs 22 (22.5%) 9 (18.4%) 13 (26.5%) 0.333 0.197 0.008
Physical and/or Sexual Abuse
 No Abuse 84 (85.7%) 42 (85.7%) 42 (85.7%) 1.000 <0.001 <0.001
 Abuse Reported 14 (14.3%) 7 (14.3%) 7 (14.3%)
Sexual Orientation Straight 22 (22.5%) 19 (38.8%) 3 (6.1%) <0.001 0.850 0.198
 Gay/Bisexual/Queer 76 (77.5%) 30 (61.2%) 46 (93.9%)
Condom Usage
 Always/Usually 71 (72.5%) 33 (67.4%) 38 (77.6%) 0.258 0.230 0.249
 Sometimes/Never 27 (27.5%) 16 (32.6%) 11 (22.4%)
Ever had STI1 – Patient Report, N = 97 47 (48.5%) 28 (57.1%) 19 (39.6%) 0.084 0.357 0.071
Any AIDS defining conditions, N = 94 34 (36.2%) 25 (51%) 9 (20%) 0.002 0.685 0.112
1Sexually Transmitted infection
2
Baseline propensity balancing results are presented in the supplemental materials of Camacho-Gonzalez et al. (2017); a cutoff of <0.25 was 
utilized to indicate covariate balance.
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